Article

Improving Treatment Strategies for Wet Age-Related Macular Degeneration

https://www.pharmacytimes.org/on-demand/improving-treatment-strategies-for-wet-agerelated-macular-degeneration

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Steven Daveluy, MD, dermatologist, Wayne State University
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Emilie Aschenbrenner, PharmD, BCOP, Froedtert Health and the Medical College of Wisconsin
Related Content
patient and doctor | Image: Adobe stock
August 16th 2025

In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy

Mary Caffrey
managed care cast banner
August 16th 2025

Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD

Mary Caffrey Skylar Jeremias Joseph Mikhael, MD
GLP-1's use, in theory should decrease preoperative risks more prevalent amongst those with obesity; however, safety considerations are still necessary. | Image Credit: AdobeStock_Anatta_Tan.jpeg
August 16th 2025

GLP-1s’ Preoperative Use Requires Safety Considerations

Sabrina McCrear
AJMC podcast banner
August 16th 2025

What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD

Hayden E. Klein Skylar Jeremias Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Chronic urticaria. | Image Credit: doucefleur - stock.adobe.com
August 16th 2025

Can Biomarkers Help Pinpoint the Right Treatment for Chronic Spontaneous Urticaria?

Cameron Santoro
While the findings suggest that switching to onasemnogene abeparvovec after non–gene therapy treatments could be beneficial to patients with spinal muscular atrophy, it is not clear which patients may benefit the most from switching therapies. | Image credit: Rochu_2008 - stock.adobe.com
August 16th 2025

Switching to Gene Therapy After Nusinersen or Risdiplam May Benefit Patients With SMA

Rose McNulty

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo